SM
BIAF icon

Sabby Management’s bioAffinity Technologies BIAF Stock Holding History

Sabby Management’s Portfolio BIAF Stock Details BIAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$297K Buy
+24,376
New +$747K 0.27% 14
2025
Q4 		– Sell
-16,184
Closed -$719K – 35
2025
Q3 		$719K Buy
+16,184
New +$1.93M 0.83% 14

Other funds holding BIAF

JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Sabby Management's BIAF Position: Q2 2026 in Review

Sabby Management opened a new position in bioAffinity Technologies (BIAF) in Q2 2026: 24,376 shares worth $297K. The stake represents 0.27% of the portfolio and ranks #14 among its holdings. This is a return to the name: Sabby Management previously reported a position in BIAF as recently as Q3 2025.

Sabby Management first reported a position in BIAF in Q3 2025 and has held it in 2 quarters since. The position peaked at $719K in Q3 2025. 18 funds tracked by Wall St. Rank hold BIAF as of Q2 2026.

  • Sabby Management held 24,376 shares of bioAffinity Technologies worth $297K as of Q2 2026.
  • bioAffinity Technologies was a new Sabby Management position in Q2 2026.
  • bioAffinity Technologies made up 0.27% of Sabby Management's portfolio in Q2 2026, its #14 holding.
  • Sabby Management first reported a position in bioAffinity Technologies in Q3 2025 and has held it in 2 quarters since.
  • Sabby Management's bioAffinity Technologies position peaked at $719K in Q3 2025.
  • 18 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q2 2026.

Based on Sabby Management's 13F filing for Q2 2026, filed 14 Aug 2026.